SCHEME 2. Synthesis of (-)-Kainic Acida
organic phase was washed with brine and dried over MgSO4,
and the volatiles were removed under reduced pressure to leave
a pale yellow oil. The oil was taken up in ethanol, the solution
was cooled to 0 °C, and NaBH4 (171 mg, 4.51 mmol) was then
added. After being stirred at 0 °C for 2.0 h, the mixture was
treated with water, followed by a few drops of HCl (1 N). The
aqueous phase was extracted with EtOAc, which was washed
with brine and dried over MgSO4. The volatiles were removed
under reduced pressure. Purification of the crude product by
silica gel flash chromatography (eluent CH2Cl2/EtOAc, 3/7)
afforded diol 6 (1.25 g, 70%) as a white solid: mp 56-57 °C;
[R]20 +230 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ 1.29
D
(m, 1H), 1.61 (m, 1H), 2.25 (m, 1H), 2.96 (d, J ) 8.8 Hz, 1H),
3.14 (dd, J ) 2.3, 11.7 Hz, 1H), 3.21 (s, 3H), 3.50 (ddd, J ) 4.0,
8.6, 10.5 Hz, 1H), 3.59 (ddd, J ) 4.7, 5.5, 10.5 Hz, 1H), 3.69 (dd,
J ) 4.7, 11.7 Hz, 1H), 4.32 (dt, J ) 2.3, 4.7 Hz, 1H), 7.23-7.61
(m, 13H); 13C NMR (75 MHz, CDCl3) δ 28.7, 48.5, 51.3, 61.2,
65.5, 71.3, 119.7, 119.9, 126.6, 127.0, 127.26, 127.34, 127.47,
127.53, 128.27, 128.32, 128.8, 139.6, 141.7, 142.9, 146.2, 147.4,
a Reaction conditions: (a) (i) H2, Pd/C, AcOH, EtOAc, 20 °C;
(ii) BCN,18 Et3N, dioxane-H2O, 20 °C; (b) AcCl, collidine, CH2Cl2,
-78 °C; (c) tosylimidazole, MeOTf, N-methylimidazole, THF, 30
°C; (d) NaOH, THF-H2O, 20 °C; (e) [CH2dC(CH3)]2CuCNLi2,
THF, -78 f 25 °C; (f) Jones reagent, acetone, 20 °C, 87%; (g)
NaOH, reflux, 86%.
176.1, 221.7; MS (ESI+) m/z 430 (MH+). Anal. Calcd for C27H27
-
NO4: C, 75.50; H, 6.34; N, 3.26. Found: C, 75.18; H, 6.43; C,
3.22.
(2S,3R,4R)-1-Benzyl 2-Methyl 4-Hydroxy-3-(2-hydroxy-
ethyl)pyrrolidine-1,2-dicarboxylate (7a). A mixture of diol
6 (1.00 g, 2.33 mmol) and 10% Pd/C (500 mg) in 0.4 mL of acetic
acid and 20 mL of ethyl acetate was placed under 5 atm of
hydrogen and stirred at 20 °C for 24 h. The reaction mixture
was filtered over Celite, which was then washed with methanol
and water. The filtrate was concentrated to dryness and the
resulting residue dissolved in 20 mL of 4:1 dioxane-water and
treated with triethylamine (1.60 mL, 11.5 mmol) followed by
BCN18 (1.40 g, 4.60 mmol). After being stirred for 24 h at 20 °C,
the mixture was treated with water and the aqueous phase was
extracted with EtOAc. The organic phase was washed with brine
and dried over MgSO4, and the volatiles were removed under
reduced pressure. Purification of the crude product by silica gel
flash chromatography (eluent EtOAc) gave the Cbz derivative
agent led in 87% yield to the corresponding acid, which
was refluxed in aqueous sodium hydroxide to afford
(-)-kainic acid (mp 239-243 °C, [R]20 -13.9 (c 0.35,
D
H2O)), indistinguishable spectroscopically and chromato-
graphically from an authentic sample of the natural
product (mp 241-243 °C, [R]20 -13.9 (c 0.31, H2O)).
D
In summary, we have described the first synthesis of
(-)-kainic acid starting from trans-4-hydroxy-L-proline.
The synthesis proceeds in >7% yield for 14 steps with
essentially total stereochemical control at the three
contiguous stereogenic centers, which places it among the
most effective reported to date. A highlight of the work
is the diastereoselective alkylation of ketone 4, the
apparent generality of which should make trans-4-
hydroxy-L-proline an even more attractive starting mate-
rial for synthesis.
7a (574 mg, 76%, two steps) as a thick oil: [R]20 -29.5 (c 1.0,
D
CHCl3); 1H NMR (300 MHz, CDCl3, mixture of rotamers) δ 1.80-
1.98 (m, 2H), 2.22-2.30 (m, 1H), 3.51 (s, 1.5H), 3.60-3.70 (m,
2.5H), 3.75 (s, 1.5H), 3.76-3.85 (m, 1.5H), 4.07 (d, J ) 9.2 Hz,
0.5H), 4.10 (d, J ) 9.1 Hz, 0.5H), 4.37 (m, 1H), 4.96 (A of AB q,
J ) 13.7 Hz, 0.5H), 5.09 (app d, J ) 1.5 Hz, 1H), 5.19 (B of AB
q, J ) 13.7 Hz, 0.5H), 7.27-7.35 (m, 5H); 13C NMR (75 MHz,
CDCl3, mixture of rotamers) δ 29.0, 48.2, 48.9, 52.0, 52.3, 54.4,
54.8, 60.8, 60.9, 62.9, 63.2, 67.2, 67.3, 70.4, 71.3, 127.8, 127.9,
128.3, 128.4, 136.2, 136.3, 154.4, 154.9, 173.0, 173.2; MS (ESI+)
m/z 346 (M + Na)+. Anal. Calcd for C16H21NO6‚0.5H2O: C, 57.82;
H, 6.67; N, 4.21. Found: C, 57.87; H, 6.69; N, 4.15.
Experimental Section
(2S,3R)-Methyl 3-(2-Methoxy-2-oxoethyl)-4-oxo-1-(9-phen-
yl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (5). A solution
of n-butyllithium (1.6 M in hexane, 3.4 mL, 5.5 mmol) was added
dropwise to a solution of ketone 412 (2.00 g, 5.22 mmol) in 10
mL of THF and 2.0 mL of HMPA at -78 °C under argon. The
resulting solution was stirred at -78 °C for 0.5 h and then
rapidly transferred with a cannula to a solution of sodium iodide
(240 mg, 1.60 mmol) and methyl bromoacetate (1.50 mL, 15.84
mmol) in 10 mL of THF at -55 °C. The reaction mixture was
allowed to warm to -40 °C, stirred for an additional 1.0 h, and
then treated with 10 mL of a 30% aqueous solution of H3PO4.
Water (10 mL) was added, and the aqueous phase was extracted
with EtOAc, which was washed with water and brine and dried
over MgSO4. The volatiles were removed under reduced pres-
sure. Purification of the crude product by silica gel flash
chromatography (eluant hexane/EtOAc, 7/3) gave keto diester
5 (1.89 g, 80%, dr 16:1) as a pale yellow oil. The spectral data
were in accord with the literature values.10b
(2S,3R,4R)-Methyl 4-Hydroxy-3-(2-hydroxyethyl)-1-(9-
phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (6). A
solution of L-Selectride (1 M in THF, 8.7 mL, 8.7 mmol) was
added to a solution of keto diester 5 (1.89 g, 4.15 mmol) in THF
at -78 °C under argon. The reaction mixture was stirred for 1
h at -78 °C and then treated with 3 N NaOH (2.9 mL, 8.7 mmol),
followed by 30% H2O2 (2.9 mL, 26.1 mmol), and allowed to warm
to 20 °C. After the mixture was stirred for 15 min, water was
added and the aqueous phase extracted with ethyl acetate. The
(2S,3R,4R)-1-Benzyl 2-Methyl 3-(2-Acetoxyethyl)-4-(tos
yloxy)pyrrolidine-1,2-dicarboxylate (8). Methyl triflate (0.278
mL, 2.46 mmol) was added dropwise to tosylimidazole (556 mg,
2.50 mmol) in 7 mL of THF at 0 °C under argon. After being
stirred for 5 min, a solution of acetate 7b (415 mg, 1.14 mmol)
and N-methylimidazole (0.200 mL, 2.51 mmol) in 7 mL of THF
was added. The reaction mixture was warmed to 30 °C and
stirred for 72 h. The reaction was then quenched by addition of
a 5% solution of aqueous KHSO4, diluted with water, and
extracted with EtOAc. The organic phase was washed brine and
dried over MgSO4, and the volatiles were removed under reduced
pressure. The crude product was purified by flash silica gel
chromatography (eluent EtOAc/hexane, 6/4 to 1/1) to afford
tosylate 8 (464 mg, 79%) as a white powder: mp 91.5 °C; [R]20
D
+49.0 (c 1.0, CHCl3); IR 2957, 1732, 1711, 1417, 1360, 1240,
1170, 896 cm-1; 1H NMR (300 MHz, CDCl3, mixture of rotamers)
δ 1.80-2.00 (m, 2H), 2.04 (s, 1.5H), 2.05 (s, 1.5H), 2.37-2.54
(m, 1H), 2.44 (s, 1.5H), 2.48 (s, 1.5H), 3.50 (s, 1.5H), 3.59 (dd, J
) 3.2, 9.7 Hz, 0.5H), 3.63 (dd, J ) 3.2, 9.5 Hz, 0.5H), 3.71-3.85
(m, 1H), 3.78 (s, 1.5H), 3.99 (dq, J ) 1.4, 6.2 Hz, 2H), 4.06 (d, J
) 9.7 Hz, 0.5H), 4.11 (d, J ) 9.5 Hz, 0.5H), 4.98 (A of AB q, J )
12.2 Hz, 0.5H), 5.07 (app t, J ) 3.7 Hz, 1H), 5.08 (A′ of A′B′ q,
J ) 12.5 Hz, 0.5H), 5.13 (B′ of A′B′ q, J ) 12.5 Hz, 0.5H), 5.18
(B of AB q, J ) 12.2 Hz, 0.5H), 7.28-7.41 (m, 7H), 7.76 (d, J )
8.4 Hz, 1H), 7.80 (d, J ) 8.3 Hz, 1H); 13C NMR (75 MHz, CDCl3,
10862 J. Org. Chem., Vol. 70, No. 26, 2005